ANGO - AngioDynamics Inc Stock Price, Fair Value and News

$13.49+0.12 (+0.90%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ANGO Price Action

Last 7 days

9.7%

Last 30 days

14.0%

Last 90 days

25.7%

Trailing 12 Months

90%

ANGO RSI Chart

ANGO Valuation

Market Cap

555.8M

Price/Earnings (Trailing)

-17.32

Price/Sales (Trailing)

1.85

EV/EBITDA

-72.11

Price/Free Cashflow

-46.74

ANGO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ANGO Fundamentals

ANGO Revenue

Revenue (TTM)

300.7M

Rev. Growth (Yr)

12.18%

Rev. Growth (Qtr)

-5.55%

ANGO Earnings

Earnings (TTM)

-32.1M

Earnings Growth (Yr)

14.81%

Earnings Growth (Qtr)

-80.21%

ANGO Profitability

EBT Margin

-10.71%

Return on Equity

-17.95%

Return on Assets

-12.08%

Free Cashflow Yield

-2.14%

ANGO Investor Care

Shares Dilution (1Y)

1.39%

Diluted EPS (TTM)

-0.78

ANGO Alerts

Losses in recent quarter

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	283.3M	292.5M	300.7M	0
2024	324.0M	303.9M	292.7M	286.5M
2023	334.7M	338.8M	335.9M	329.5M
2022	306.1M	316.2M	320.8M	327.9M
2021	272.5M	291.0M	297.8M	303.3M
2020	277.0M	264.2M	268.3M	271.1M
2019	265.6M	270.6M	272.7M	272.8M
2018	282.4M	261.7M	260.7M	264.1M
2017	356.1M	349.6M	326.5M	304.0M
2016	351.2M	353.9M	358.2M	358.0M
2015	359.9M	356.5M	353.2M	350.3M
2014	360.1M	360.1M	359.9M	359.9M
2013	318.1M	354.4M	358.1M	361.7M
2012	220.2M	221.8M	251.0M	281.5M
2011	215.7M	215.6M	218.5M	223.3M
2010	0	0	0	215.8M

Get all data in R, Python etc through our Historical Stock Data APIs

About AngioDynamics Inc

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

CEO	Mr. James C. Clemmer
WEBSITE	angiodynamics.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	815

AngioDynamics Inc Frequently Asked Questions

What is the ticker symbol for AngioDynamics Inc? What does ANGO stand for in stocks?

ANGO is the stock ticker symbol of AngioDynamics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AngioDynamics Inc (ANGO)?

As of Wed Dec 03 2025, market cap of AngioDynamics Inc is 555.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ANGO stock?

You can check ANGO's fair value in chart for subscribers.

Is AngioDynamics Inc a good stock to buy?

The fair value guage provides a quick view whether ANGO is over valued or under valued. Whether AngioDynamics Inc is cheap or expensive depends on the assumptions which impact AngioDynamics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ANGO.

What is AngioDynamics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ANGO's PE ratio (Price to Earnings) is -17.32 and Price to Sales (PS) ratio is 1.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ANGO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on AngioDynamics Inc's stock?

In the past 10 years, AngioDynamics Inc has provided 0.01 (multiply by 100 for percentage) rate of return.